68-4

99/136

information in elderly patients with heart failure. J Cardiol, 2020; 76: 350-356. 36) Yoshioka K, Matsue Y, Okumura T, Kida K, Oishi S, Akiyama E, Suzuki S, Yamamoto M, Mizukami A, Kuroda S, Kagiyama N, Yama-guchi T, Sasano T, Matsumura A, Kitai T: Impact of brain natriuretic peptide reduction on the worsening renal function in patients with acute heart failure. PLoS One, 2020; 15: e0235493. 37) Matsue Y, Kamiya K, Saito H, Saito K, Ogas-ahara Y, Maekawa E, Konishi M, Kitai T, Iwata K, Jujo K, Wada H, Kasai T, Nagamatsu H, Ozawa T, Izawa K, Yamamoto S, Aizawa N, Yonezawa R, Oka K, Momomura SI, Kagi-yama N: Prevalence and prognostic impact of the coexistence of multiple frailty domains in elderly patients with heart failure: The FRAGILE-HF cohort study. Eur J Heart Fail, 2020; 22: 2112-2119. 38) Matsue Y, Kagiyama N, Yamaguchi T, Kuroda S, Okumura T, Kida K, Mizuno A, Oishi S, Inuzuka Y, Akiyama E, Matsukawa R, Kato K, Suzuki S, Naruke T, Yoshioka K, Miyoshi T, Baba Y, Yamamoto M, Mizutani K, Yoshida K, Kitai T: Clinical and Prognostic Values of ALBI Score in Patients With Acute Heart Failure. Heart Lung Circ, 2020; 29: 1328-1337. 39) Motiejūnaitė J, Akiyama E, Cohen-Solal A, Maggioni AP, Mueller C, Choi DJ, Kavoliu-niene A, Celutkiene J, Parenica J, Lassus J, Kajimoto K, Sato N, Miró Ò, Peacock WF, Matsue Y, Voors AA, Lam CSP, Ezekowitz JA, Ahmed A, Fonarrow GC, Gayat E, Regitz-Zagrosek V, Mebazaa A: The associa-tion of long-term outcome and biological sex in patients with acute heart failure from different geographic regions. Eur Heart J, 2020; 41: 1357-1364. 40) Kitai T, Xanthopoulos A, Tang WHW, Kaji S, Furukawa Y, Oishi S, Akiyama E, Suzuki S, Yamamoto M, Kida K, Okumura T, Skoular-igis J, Triposkiadis F, Matsue Y: Validation of the Larissa Heart Failure Risk Score for risk stratification in acute heart failure. Int J Cardiol, 2020; 307: 119-124. 41) Matsue Y. Are Obese Patients With Heart Failure Very Different From Non-Obese Patients? J Card Fail, 2020; 26: 118-119. 42) Kato T, Kasai T, Sato A, Ishiwata S, Yatsu S, Matsumoto H, Shitara J, Murata A, Shimizu M, Suda S, Hiki M, Naito R, Daida H: Effects of 3-Month astaxanthin supplementation on cardiac function in heart failure patients with left ventricular systolic dysfunction-a pilot study. Nutrients, 2020; 12: E1896. 43) Docherty KF, Jhund PS, Bengtsson O, DeMets DL, Inzucchi SE, Køber L, Kosiborod MN, Langkilde AM, Martinez FA, Sabatine MS, Sjöstrand M, Solomon SD, McMurray JJV; DAPA-HF Investigators and Commit-tees: Effect of Dapagliflozin in DAPA-HF According to Background Glucose-Lowering Therapy. Diabetes Care, 2020; 43: 2878-2881. 44) Ishiwata S, Yatsu S, Kasai T, Sato A, Matsu-moto H, Shitara J, Shimizu M, Murata A, Kato T, Suda S, Doi S, Hiki M, Matsue Y, Naito R, Iwata H, Takagi A, Daida H: Prog-nostic effect of a novel simply calculated nutritional index in acute decompensated heart failure. Nutrients, 2020; 12: E3311. 45) Nemoto M, Nakashima K, Noma S, Matsue Y, Yoshida K, Matsui H, Shiraishi A, Ishifuji T, Morimoto K, Ariyoshi K, Aoshima M: Prog-nostic value of chest computed tomography in community-acquired pneumonia patients. ERJ Open Res, 2020; in-press. 46) Konishi M, Kagiyama N, Kamiya K, Saito H, Saito K, Ogasahara Y, Maekawa E, Misumi T, Kitai T, Iwata K, Jujo K, Wada H, Kasai T, Nagamatsu H, Ozawa T, Izawa K, Yamamoto S, Aizawa N, Makino A, Oka K, Momomura SI, Matsue Y: Impact of sarcopenia on prog-nosis in patients with heart failure with reduced and preserved ejection fraction. Eur J Prev Cardiol, 2020; in-press. 47) Ito M, Matsue Y, Minamino T: Worsening renal function during intensive blood pres-sure control: another example of not prognos-tically relevant creatinine rise? Eur J Heart Fail, 2020; in-press. 48) Kimura Y, Kasai T, Tomita Y, Kasagi S, Takaya H, Kato M, Kawana F, Narui K: Rela-tionship between metabolic syndrome and hypercapnia among obese patients with sleep apnea. World J Respirol, 2020; 10: 1-10. 49) Murase K, Tanizawa K, Minami T, Matsu-moto T, Tachikawa R, Takahashi N, Tsuda 419